Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

Estimating disease risk in families carrying changes in C9orf72 gene

Original source

Estimating disease risk in families carrying changes in C9orf72 geneMotor Neurone Disease Association (UK) · 5 December 2025 (opens in a new tab)

Related topics

An Oxford research presentation estimated that people carrying a C9orf72 repeat expansion had a 64% chance of developing a neurodegenerative disease by age 80. The estimate came from family-history data covering 52 families, but risk varied from 27% to 100% between families. Most diagnosed participants had amyotrophic lateral sclerosis (ALS), rather than another neurodegenerative disease.

Why this matters

The findings suggest that family history could eventually help provide more personalised risk estimates for people carrying a C9orf72 expansion. This does not change treatment or provide an individual prediction yet; further research is needed to improve and validate the estimates.

Limitations and context

The source is an organisational research blog reporting on a presentation, not a peer-reviewed research paper. The analysis included 758 of 1,110 people from 52 families, and the reported estimates varied substantially between families. The source does not provide enough methodological detail to assess the analysis fully.

Summarised by Compass 9 August 2026 · reported from England

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?